A股異動 | 慧博雲通跌近6% 未進行ChatGPT相關的底層神經網絡算法的技術研發
格隆匯2月10日丨慧博雲通跌近6%,報32.59元,總市值130億元。慧博雲通昨日公佈,公司於近日注意到媒體報道公司涉及“ChatGPT”概念相關事項,且部分投資者在深圳證券交易所互動易平台上詢問公司關於“ChatGPT”、“ChatBot”的相關情況。現予以澄清説明,截至目前,公司未進行ChatGPT相關的底層神經網絡算法的技術研發,也未參與百度的“文心一言”項目或360等公司推出的ChatGPT相關項目。關於公司涉及“ChatGPT”業務的報道不屬實,公司人工智能業務在公司整體業務中佔比不大。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.